12/20/2024
6:05 AM | Eton Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
6:05 AM | Eton Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
3:30 PM | Eton Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
3:27 PM | Eton Pharmaceuticals (Filer)
| Form 424B5 | |
12/09/2024
4:11 PM | Erdogan-Trinkaus Ipek (Reporting)
Eton Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/03/2024
6:00 AM | Eton Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2024
6:00 AM | Eton Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
11/07/2024
6:05 AM | Eton Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
3:05 PM | Eton Pharmaceuticals (Issuer)
Opaleye Management Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
5:34 PM | Eton Pharmaceuticals (Issuer)
Opaleye Management Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:19 PM | Eton Pharmaceuticals (Issuer)
Krempa David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
5:30 AM | Eton Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
6:31 PM | Eton Pharmaceuticals (Issuer)
Opaleye Management Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:05 PM | Eton Pharmaceuticals (Issuer)
Opaleye Management Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
3:05 PM | Eton Pharmaceuticals (Subject)
Opaleye Management Inc. (Filed by)
| Form SC 13G/A | |
08/08/2024
3:25 PM | Eton Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024
3:16 PM | Eton Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
3:16 PM | Eton Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:17 PM | Eton Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:25 PM | Eton Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2024
6:15 AM | Eton Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
6:00 AM | Eton Pharmaceuticals (Subject)
HARROW, INC. (Filed by)
HARROW, INC. (Filed by)
HARROW, INC. (Filed by)
| Form SC 13D/A | |
04/26/2024
3:21 PM | Eton Pharmaceuticals (Filer)
| Form DEF 14A | |
04/18/2024
3:22 PM | Eton Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
3:24 PM | Eton Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/22/2024
5:55 AM | Eton Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
5:55 AM | Eton Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
3:15 PM | Eton Pharmaceuticals (Issuer)
RIEDEL NORBERT G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:16 PM | Eton Pharmaceuticals (Issuer)
MAIER PAUL V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:17 PM | Eton Pharmaceuticals (Issuer)
Krempa David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:18 PM | CASAMENTO CHARLES J (Reporting)
Eton Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:19 PM | BRYNJELSEN SEAN (Reporting)
Eton Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:19 PM | Adams Jennifer McKie (Reporting)
Eton Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:21 PM | Eton Pharmaceuticals (Issuer)
Gruber James R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
5:55 AM | Eton Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
